Abstract
Mark your calendars! On behalf of the annual meeting Program Committee, we are excited to welcome you and your guests to the 94th annual meeting of the American Thyroid Association (ATA) from September 10 to 14, 2025, at the Westin Kierland in sunny Scottsdale, AZ.
The Program Committee, made up of a diverse and multidisciplinary group of thyroid experts from around the world, has been working diligently since even before the last ATA annual meeting in Chicago, IL, to develop a fantastic program. We aim to bring you not only the most exciting recent advances in basic, translational, and clinical thyroid topics, but based on past-attendee feedback, we have also created a new Core Thyroidology track to provide a broad foundational education in thyroid disease management. Here is a sneak peek of the upcoming meeting!
Pre-Meeting Programs, Wednesday, September 10, 2025
Back by popular demand, we have a full day of pre-meeting sessions planned. We will offer the annual E. Chester Ridgway Conference specifically designed for trainees and early career professionals, which this year is co-chaired by Drs. Iñigo Landa and Melissa Lechner. The Ridgway Conference provides a comprehensive foundation in thyroid research and clinical practice as well as networking opportunities with leading thyroid experts. This is a perfect springboard for the annual meeting program, and especially the Core Thyroidology track, which dives deeper and expands upon this foundational course.
We will be offering two opportunities for hands-on learning: the advanced ultrasound course, led by Drs. Susan Mandel and Kevin Brumund, and the Interventional Endocrinology workshop, led by Drs. Ralph Tufano, Chelsey Baldwin, and Leonardo Rangel, which will allow attendees to gain foundational skills or hone advanced techniques in thyroid and neck ultrasound and procedures. Finally, we are again offering an exciting and interactive leadership development workshop, titled “The Art and Science of Leading Through Pressure: Conflict, Change and Culture in Modern Medicine.”
ATA Annual Meeting, Thursday–Sunday, September 11–14, 2025
We are pleased to bring you an exciting and educational program including plenaries, symposia, debates, guideline updates and practical applications, panel discussions, meet the professors, and thyroid dialogue networking sessions as well as our scientific abstract oral and poster presentations. The Program Committee is excited to bring attendees a new track this year, Core Thyroidology, which aims to provide a longitudinal set of sessions that provide a foundational knowledge of thyroid disease and management ideal for early career or newly subspecializing clinicians as well as trainees and advanced practice clinicians. Basic science sessions are also curated into a longitudinal track for easy navigation.
We will kick off the meeting on Thursday, September 11, with the much-anticipated basic, clinical, and surgical year in thyroidology presented by Drs. Aime Franco, Bryan Haugen, and Louise Davies, respectively, where we will hear about the most impactful advances and publications over the previous year.
For this year’s Sawin Lecture, Dr. Gregory Brent will discuss the path to understanding thyroid hormone action over the past 130 years on Friday, September 12.
Guidelines
In response to feedback, this year our guidelines sessions will focus on the application of new recommendations in clinical practice and highlighting differences with previous guidelines. The “Applying the Guidelines” sessions include (i) Thyroid Cancer chaired by Drs. Matt Ringel and Julie Ann Sosa, (ii) Thyroid Nodules chaired by Drs. Susan Mandel and Lisa Orloff, (iii) Thyroid Diseases in Pregnancy chaired by Drs. Angela Leung and Elizabeth Pearce, and (iv) Pediatric Thyroid Cancer, chaired by Drs. Steven Waguespack, Andrew Bauer, and Jonathan Wasserman. In addition, the Hypothyroidism guidelines session will focus on the challenges and potential solutions faced by the working group and is chaired by Drs. Maria Papaleontiou and Jennifer Mammen.
Thyroid disorders
Drs. Chrysoula Dosiou and Jennifer Eaton will debate whether to treat thyrotropin (TSH) concentrations 2.4–4.0 mIU/L in thyroid peroxidase antibody (TPO-Ab)-positive pregnant women. We will have a symposium on thyroid autoimmunity where the maternal and fetal implications of thyroid antibodies during pregnancy, the management of stimulating, blocking and neutral TSH-receptor antibodies, and the impact of reducing TPO antibodies on thyroid diseases will be discussed by Drs. Linda Barbour, Giuseppe Barbesino, and Marco Medici, respectively. An update on thyroid eye disease will focus on the pathophysiology, novel immunological treatments, and the role of natural remedies with presentations by Drs. Terry Davies, Amy Patel, and Trevor Angell.
Thyroid nodules
Chaired by Drs. Kepal Patel and Kaitlyn Frazier, a multidisciplinary session on Alternative Treatment Strategies for Thyroid Nodules will begin with an overview of different interventional technologies such as radiofrequency and microwave ablation and their clinical application by Drs. Richard Harding and Mayumi Endo, followed by a lively debate between Drs. Jonathan Russell and Sareh Parangi for and against remote access thyroid surgery.
Thyroid cancer
For the first time, we have a joint symposium with the Society of Nuclear Medicine and Molecular Imaging on Friday, September 12, to highlight clinical practice challenges in administering radioactive iodine, chaired by Drs. Sara Ahmadi and Kaniksha Desai. We are also excited to have a symposium dedicated to anaplastic thyroid cancer with Drs. James Fagin, Gregory Randolph, and Maria Cabanillas, discussing novel molecular insights, when to operate and personalized treatment. Drs. Yuri Nikiforov, Dan Rocke, and Benjamin Gigliotti will discuss the pathology, management, and follow-up of oncocytic thyroid carcinomas. The surgical management, focused therapies for metastases and systemic therapies in RET- and non-RET mutated cancers will be discussed by Drs. Nitin Pagedar, Nancy Lee, and Mimi Hu in the medullary thyroid cancer symposium. Drs. Cord Sturgeon, Ramona Dadu, Lori Worth, and Antoine Eksander will highlight the assessment of advanced differentiated thyroid cancer, when and how to operate and neoadjuvant therapy options. Finally, we look forward to a session on improving care for patients with thyroid cancer focusing on barriers and facilitators to patient access, selecting high volume physicians, and addressing to follow-up presented by Drs. Debbie Chen, Febi Zheng, Tracy Wang, Malini Gupta, and Stephanie Smooke-Praw.
Voice and thyroid
New this year, we are pleased to offer a symposium on voice and thyroid co-moderated by Drs. Dave Francis and Greg Randolph. This session will feature presentations from Vaninder Dhillon, MD, and Kristine Pietsch, SLP, on how to identify voice issues both preoperatively and postoperatively in patients with thyroid; Dr. Catherine Sinclair on radiofrequency ablation and voice; and from Dr. Dianna Kirke on voice outcomes after thyroid surgery.
Surgical
The dedicated surgical symposium to be held on Friday, September 12, and chaired by Drs. Julia Noel and Catherine McMannus will delve into perspectives on surgical de-escalation for differentiated thyroid cancer and options for management of thyroid goiter. It promises to be a thought-provoking and interactive experience and features an impressive lineup of renowned experts.
Also of interest to surgeons, this year the Surgical Affairs Committee will be offering an Early Riser prep course for the American Board of Surgery/American Board of Otolaryngology – Head and Neck Surgery (ABS/ABOHNS) Thyroid & Parathyroid Surgery Focused Practice Designation (FPD) Exam and a reception networking event for all of those who were in the first cohort to earn the FPD this year.
Pediatrics
The dedicated pediatric symposium to be held on Saturday, September 13, and moderated by Drs. Zoltan Antal and Briana Patterson will cover targeted therapies for fusion-driven thyroid cancer, thyroid cancer predisposition syndromes, transition to adult medicine, and management of pediatric Graves’ disease.
Artificial intelligence
You will hear from Dr. Juan Brito about the current applications, associated challenges, and future directions of artificial intelligence in thyroidology. Dr. Pia Pace-Asciak will highlight future directions in the treatment of thyroid and parathyroid.
Basic and translational sessions
The Basic Science Track this year will feature 10 symposiums/sessions, and all clinical sessions will have an opposing basic or translational science option. Featured topics include sessions on deciphering new molecular targets in thyroid cancer, thyroid receptors (TR) and chromatin modification, deiodinases in diseases, novel TR-alpha-1 functions, TR signaling and tissue regeneration, and organoids as a model to study physiology and pathology.
Translational symposia will cover thyroid consequences of cancer immune therapy, advances in combinatorial drug strategies to target thyroid cancer, mechanisms and implications of metabolic shifts in thyroid cancer, and uncommon drivers in thyroid malignancies.
Other featured events
The meeting will feature the announcements of the annual ATA Awards and Award Lectures. A plenary session planned by Women in Thyroidology will include a panel discussion relating to educating the next generation of Thyroidologists. In addition, networking sessions have been organized around topics such as Thyroid Cancer Disparities and Access to Care, Training Program Directors, and Basic Science.
On Sunday September 14, we will wrap up the meeting with a perennial favorite, the Thyroid Tumor Board, chaired by Drs. Lindsay Bischoff and Leila Morris-Wiseman, which will feature a full bench of multidisciplinary expert panelists Drs. Amanda La Greca (Endocrinology), Joseph Scharphf (Head & Neck surgery), Marcia Brose (Medical Oncology), Seza Gulec (Nuclear Medicine), Sarimar Agusto-Salgado (Oncologic Endocrine), and Stacey Gargano (Pathology).
Social events
We will have an all-attendee photo Thursday night immediately preceding the Bobbi Smith Networking Social. On Saturday evening, the Annual Meeting Closing Party will feature appetizers, drinks, and dancing.
To see the entire program, please visit the ATA website. We can’t wait to see you in sunny Scottsdale!
Footnotes
Acknowledgments
The authors would like to thank all the members of the Program Steering Committee and the Program Committee for their many contributions to the meeting agenda. The Steering Committee includes Drs. Sara Ahmadi, Nicholas Bambach, Sheue-yann Chen, Abbey Fingeret, and Maya Lodish. The Program Committee members are Drs. Zoltan Antal, Kaniksha Shekhar Desai, Sina Jasim, Salma Khan, Sarah Oltmann, Martin Read, Federico Salas-Lucia, Steven Sherman, David Shonka, and Thomas Yamashita. The authors are also very grateful to the ATA leadership and staff (Pamela Mechler, Dena Silva, Kelly Hoff, Claudia Crail-Muñoz, Carrie Prewitt, Sharleene Cano, and Gwynn Breckenridge) for the work they do behind the scenes to organize and bring together a fantastic program and help everything run smoothly.
Authors’ Contributions
E.E.C.: Conceptualization, data collection, writing—original draft, writing—review and editing, approval of final version to be published, and accountable for all aspects of the work. K.B.: Conceptualization, data collection, writing—original draft, writing—review and editing, approval of final version to be published, and accountable for all aspects of the work.
Author Disclosure Statement
E.E.C. has no conflicts to declare. K.B. is on the Advisory Board (Consultant) for Eli Lilly, Argenx, Amgen, SERB, and Egetis Pharmaceuticals.
Funding Information
No funding was received for this article.